Our vision is to bridge the gap between genomics and cell analysis by harnessing CRISPR technology to develop a simple and scalable approach to detect any DNA and RNA biomarker directly in cells and tissue. Our assay and reagent products will be compatible with the large and existing installed base of flow cytometers and microscopes that are routinely used today in most research and clinical diagnostic labs for cell and tissue analysis.